ABCL-615: EPCORE NHL-6: Phase 2 Study of Subcutaneous Epcoritamab as Outpatient Treatment for 2L+ Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Christina Y. Lee, David Andorsky, Ralph Boccia, Adelba Torres Lopez et autres
0 citationsClinical Lymphoma Myeloma & Leukemia